Literature DB >> 18637670

2-Amino-6-furan-2-yl-4-substituted nicotinonitriles as A2A adenosine receptor antagonists.

Monica Mantri1, Olivier de Graaf, Jacobus van Veldhoven, Anikó Göblyös, Jacobien K von Frijtag Drabbe Künzel, Thea Mulder-Krieger, Regina Link, Henk de Vries, Margot W Beukers, Johannes Brussee, Adriaan P Ijzerman.   

Abstract

A 2A adenosine receptor antagonists usually have bi- or tricyclic N aromatic systems with varying substitution patterns to achieve desired receptor affinity and selectivity. Using a pharmacophore model designed by overlap of nonxanthine type of previously known A 2A antagonists, we synthesized a new class of compounds having a 2-amino nicotinonitrile core moiety. From our data, we conclude that the presence of at least one furan group rather than phenyl is beneficial for high affinity on the A 2A adenosine receptor. Compounds 39 (LUF6050) and 44 (LUF6080) of the series had K i values of 1.4 and 1.0 nM, respectively, with reasonable selectivity toward the other adenosine receptor subtypes, A 1, A 2B, and A 3. The high affinity of 44 was corroborated in a cAMP second messenger assay, yielding subnanomolar potency for this compound.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18637670     DOI: 10.1021/jm701594y

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  20 in total

1.  Synthesis and anticholinesterase activity of novel non-hepatotoxic naphthyridine-11-amine derivatives.

Authors:  Belma Zengin Kurt
Journal:  Mol Divers       Date:  2018-12-04       Impact factor: 2.943

2.  Ligand binding and subtype selectivity of the human A(2A) adenosine receptor: identification and characterization of essential amino acid residues.

Authors:  Veli-Pekka Jaakola; J Robert Lane; Judy Y Lin; Vsevolod Katritch; Adriaan P Ijzerman; Raymond C Stevens
Journal:  J Biol Chem       Date:  2010-02-10       Impact factor: 5.157

3.  Functional selectivity of adenosine A1 receptor ligands?

Authors:  Ellen V Langemeijer; Dennis Verzijl; Stefan J Dekker; Ad P Ijzerman
Journal:  Purinergic Signal       Date:  2012-09-28       Impact factor: 3.765

4.  In Silico Studies Targeting G-protein Coupled Receptors for Drug Research Against Parkinson's Disease.

Authors:  Agostinho Lemos; Rita Melo; Antonio Jose Preto; Jose Guilherme Almeida; Irina Sousa Moreira; Maria Natalia Dias Soeiro Cordeiro
Journal:  Curr Neuropharmacol       Date:  2018       Impact factor: 7.363

5.  Pharmacophore modeling of human adenosine receptor A(₂A) antagonists.

Authors:  Zhejun Xu; Feixiong Cheng; Chenxiao Da; Guixia Liu; Yun Tang
Journal:  J Mol Model       Date:  2010-03-12       Impact factor: 1.810

6.  Structure based prediction of subtype-selectivity for adenosine receptor antagonists.

Authors:  Vsevolod Katritch; Irina Kufareva; Ruben Abagyan
Journal:  Neuropharmacology       Date:  2010-07-15       Impact factor: 5.250

7.  Structure-based discovery of novel chemotypes for adenosine A(2A) receptor antagonists.

Authors:  Vsevolod Katritch; Veli-Pekka Jaakola; J Robert Lane; Judy Lin; Adriaan P Ijzerman; Mark Yeager; Irina Kufareva; Raymond C Stevens; Ruben Abagyan
Journal:  J Med Chem       Date:  2010-02-25       Impact factor: 7.446

8.  The 2.6 angstrom crystal structure of a human A2A adenosine receptor bound to an antagonist.

Authors:  Veli-Pekka Jaakola; Mark T Griffith; Michael A Hanson; Vadim Cherezov; Ellen Y T Chien; J Robert Lane; Adriaan P Ijzerman; Raymond C Stevens
Journal:  Science       Date:  2008-10-02       Impact factor: 47.728

9.  2-Amino-6-(naphthalen-1-yl)-4-phenyl-pyridine-3-carbonitrile.

Authors:  Wei Mao; Cheng Guo; Wei Wang; Chang-Jun Luan; Ren-Jun Du
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2011-03-12

10.  2-Amino-4-(3-fluoro-phen-yl)-6-(naphthalen-1-yl)pyridine-3-carbonitrile.

Authors:  Jia-Ying Xu; Zhao-Chang Gao; Kai-Jin Sun; Wei-Hua Cheng
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2010-11-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.